To elucidate the mechanisms by which CXCR4 antagonism reduces AF inducibility, we evaluated the effect of CXCR4 on the alteration of CD3+ T lymphocytes, CD20+ B lymphocytes and F4/80+ macrophages in the atria using IHC. The gene discussed is CXCR4; the disease is atrial fibrillation.